𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alemtuzumab therapy in B-cell lymphoproliferative disorders

✍ Scribed by Paul Moreton; Peter Hillmen

Book ID
114106641
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
99 KB
Volume
30
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoplastic Hematopathology Volume 219 ||
Neoplastic Hematopathology Volume 219 || Therapy of B-cell Lymphoproliferative Disorders
✍ Jones, Dan πŸ“‚ Article πŸ“… 2009 πŸ› Humana Press 🌐 English βš– 632 KB

Fulfilling the void with a Hematopathology book that integrates clinical and experimental studies with diagnostic criteria, Neoplastic Hematopathology: Experimental and Clinical Approaches provides an overview of the discipline of hematopathology that connects the field with recent advances in immun

Phase II study of alemtuzumab in chronic
Phase II study of alemtuzumab in chronic lymphoproliferative disorders
✍ Alessandra Ferrajoli; Susan M. O'Brien; Jorge E. Cortes; Francis J. Giles; Debor πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract ## BACKGROUND Pilot studies showed that alemtuzumab is active in lymphoproliferative disorders. The authors conducted a Phase II trial to evaluate the efficacy and safety of alemtuzumab in advanced or refractory chronic lymphoproliferative disorders. ## METHODS Seventy‐eight patients